These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 413839)

  • 1. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
    J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of aspirin and diflunisal on prostaglandin synthetase from human platelets and sheep seminal vesicles.
    Majerus PW; Stanford N
    Br J Clin Pharmacol; 1977 Feb; 4 Suppl 1(Suppl 1):15S-18S. PubMed ID: 406909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of hepatic and extrahepatic metabolism of aspirin in selective inhibition of platelet cyclooxygenase.
    Roberts MS; Cossum PA; Kilpatrick D
    N Engl J Med; 1985 May; 312(21):1388-9. PubMed ID: 3921841
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein.
    Roth GJ; Majerus PW
    J Clin Invest; 1975 Sep; 56(3):624-32. PubMed ID: 1159076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of interaction of acetylsalicylic acid and indomethacin with endoperoxide prostaglandin synthetase].
    Muratov VK; Igumnova ND; Basevich VV; Churiukanov VV; Mevkh AT
    Farmakol Toksikol; 1983; 46(5):44-8. PubMed ID: 6414841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of aspirin and indomethacin on human platelet prostaglandin synthetase.
    Crook D; Collins AJ
    Ann Rheum Dis; 1977 Oct; 36(5):459-63. PubMed ID: 411427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects.
    Patrignani P; Filabozzi P; Patrono C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():259-64. PubMed ID: 6221533
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
    Halushka MK; Walker LP; Halushka PV
    Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmune assay of human platelet prostaglandin synthetase.
    Roth GJ; Machuga ET
    J Lab Clin Med; 1982 Feb; 99(2):187-96. PubMed ID: 6801166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing aspirin-induced attenuation of platelet reactivity by flow cytometry.
    Hübl W; Assadian A; Lax J; Meixner U; Fang IF; Hagmüller G; Panzer S; Bayer PM
    Thromb Res; 2007; 121(1):135-43. PubMed ID: 17467777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid metabolism and inhibition of cyclooxygenase in platelets from asthmatic subjects with aspirin intolerance.
    Bonne C; Moneret-Vautrin DA; Wayoff M; Descharmes A; Gazel P; Legrand A; Kalt C
    Ann Allergy; 1985 Feb; 54(2):158-60. PubMed ID: 3918485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylation of prostaglandin synthase by aspirin.
    Roth GJ; Stanford N; Majerus PW
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3073-6. PubMed ID: 810797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demonstration of specific platelet function anomaly in asthma induced by aspirin: diagnostic consequences].
    Ameisen JC; Joseph M; Tonnel AB; Vorng H; Pancré V; Fournier E; Wallaert B; Capron A
    C R Acad Sci III; 1985; 300(4):137-42. PubMed ID: 3919888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.